title: Management of common arrhythmias: Part I. Supraventricular arrhythmias.
abstract: Family physicians frequently encounter patients with symptoms that could be related to cardiac arrhythmias, most commonly atrial fibrillation or supraventricular tachycardias. The initial management of atrial fibrillation includes ventricular rate control to provide adequate cardiac output. In patients with severely depressed cardiac output and recent-onset atrial fibrillation, immediate electrical cardioversion is the treatment of choice. Hemodynamically stable patients with atrial fibrillation for more than two days or for an unknown period should be assessed for the presence of atrial thrombi. If thrombi are detected on transesophageal echocardiography, anticoagulation with warfarin for a minimum of 21 days is recommended before electrical cardioversion is attempted. Patients with other supraventricular arrhythmias may be treated with adenosine, a calcium channel blocker, or a short-acting beta blocker to disrupt reentrant pathways. When initial medications are ineffective, radiofrequency ablation of ectopic sites is an increasingly popular treatment option.
authors.affiliation: Department of Family Medicine, Medical University of South Carolina, Charleston 29425, USA. huestowj@musc.edu
authors.forename: A Kesh
authors.initials: AK
authors.lastname: Hebbar
authors.forename: William J
authors.initials: WJ
authors.lastname: Hueston
mesh_terms: D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D001281:Atrial Fibrillation / Q000175:diagnosis; D017548:Echocardiography, Transesophageal; D004554:Electric Countershock; D004562:Electrocardiography; D006801:Humans; D017410:Practice Guidelines as Topic; D013617:Tachycardia, Supraventricular / Q000628:therapy; D014636:Valsalva Maneuver
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone